EARLY INTERVENTION REFERENCES

1.            Bonow, R.O., et al., ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in Collaboration With the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation, 2006. 114(5): p. e84-e231.

2.            Clark, M.A., et al., Five-year Clinical and Economic Outcomes Among Patients With Medically Managed Severe Aortic Stenosis: Results From a Medicare Claims Analysis. Circulation: Cardiovascular Quality and Outcomes, 2012. 5(5): p. 697-704.

3.            Roger, V.L., et al., Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation, 2011. 123(4): p. e18-e209.

4.            Nkomo, V.T., et al., Burden of valvular heart diseases: a population-based study. Lancet, 2006. 368(9540): p. 1005-11.

5.            Zhao, Y., A. Owen, and M. Henein, Early valve replacement for aortic stenosis irrespective of symptoms results in better clinical survival: A meta-analysis of the current evidence. Int J Cardiol, 2013.

6.            Brown, M.L., et al., The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg, 2008. 135(2): p. 308-15.

7.            Kang, D.H., et al., Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation, 2010. 121(13): p. 1502-9.

8.            Bach, D.S., et al., Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes, 2009. 2(6): p. 533-9.

9.            Iung, B., et al., Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J, 2005. 26(24): p. 2714-20.

10.          Iung, B. and A. Vahanian, Degenerative calcific aortic stenosis: a natural history. Heart, 2012. 98 Suppl 4: p. iv7-13.

11.          Osnabrugge, R.L., et al., Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention, 2013. 9 Suppl: p. S48-54.

12.          Reynolds, M.R., et al., Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation, 2012. 125(9): p. 1102-9.

13.          Reynolds, M.R., et al., Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol, 2012. 60(25): p. 2683-92.

14.          Osnabrugge, R.L., et al., Patient selection for transcatheter aortic valve replacement: what does the future hold? Expert Rev Cardiovasc Ther, 2012. 10(6): p. 679-81.

15.          Pellikka, P.A., et al., Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation, 2005. 111(24): p. 3290-5.

16.          Otto, C.M., Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol, 2006. 47(11): p. 2141-51.

17.          Osnabrugge, R.L., et al., Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg, 2013. 96(2): p. 500-6.

 

Enhanced by Zemanta

Speak Your Mind

*

Share This